Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Atypical Antipsychotic [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
CLOZAPINE 95,558 15,347 16.1% 41,887 5,266 47.0 yrs 38.0%
RISPERIDONE 79,288 4,120 5.2% 18,771 2,821 31.9 yrs 15.6%
QUETIAPINE 73,260 13,610 18.6% 31,386 7,858 46.9 yrs 58.7%
ARIPIPRAZOLE 66,335 3,863 5.8% 20,713 3,238 39.1 yrs 55.7%
OLANZAPINE 51,444 5,535 10.8% 21,934 4,612 44.3 yrs 46.1%
PIMAVANSERIN 46,338 12,352 26.7% 7,471 70 76.5 yrs 38.7%
PALIPERIDONE 40,949 1,809 4.4% 8,499 845 38.9 yrs 33.6%
LURASIDONE 17,232 709 4.1% 2,381 316 40.7 yrs 68.2%
BREXPIPRAZOLE 13,270 673 5.1% 1,269 121 50.5 yrs 69.0%
CARIPRAZINE 6,547 194 3.0% 702 70 40.4 yrs 64.0%

Head-to-Head Comparisons

CLOZAPINE vs RISPERIDONE CLOZAPINE vs QUETIAPINE CLOZAPINE vs ARIPIPRAZOLE CLOZAPINE vs OLANZAPINE RISPERIDONE vs QUETIAPINE RISPERIDONE vs ARIPIPRAZOLE RISPERIDONE vs OLANZAPINE QUETIAPINE vs ARIPIPRAZOLE QUETIAPINE vs OLANZAPINE ARIPIPRAZOLE vs OLANZAPINE
← Back to Atypical Antipsychotic [EPC] Class side effects →